DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0036439 | Scoliosis, unspecified | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0003469 | Anxiety Disorders | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0520947 | Clumsiness - motor delay | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0497327 | Dementia | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0005684 | Malignant neoplasm of urinary bladder | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0026850 | Muscular Dystrophy | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0241005 | Creatine phosphokinase serum increased | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0011265 | Presenile dementia | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0038379 | Strabismus | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0151779 | Cutaneous Melanoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0699743 | Congenital muscular dystrophy (disorder) | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0278878 | Adult Glioblastoma | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0748607 | Recurrent seizure | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0004936 | Mental disorders | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0002395 | Alzheimer's Disease | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C3714756 | Intellectual Disability | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C4721453 | Peripheral Nervous System Diseases | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0017205 | Gaucher Disease | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0162830 | Dermatitis, Phototoxic | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0007114 | Malignant neoplasm of skin | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0393591 | AICARDI-GOUTIERES SYNDROME | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0004153 | Atherosclerosis | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0013336 | Dwarfism | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0009691 | Congenital cataract | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0005695 | Bladder Neoplasm | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024